Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
CrossMark
Data Policies
EDITORIAL
Seasonal Influenza Guidelines update
1
6th Department of Pneumonology, Hospital
for Diseases of the Chest, “Sotiria”, Medical School, National and
Kapodistrian University of Athens, Athens,
Greece
2
First Academic Department of
Pneumonology, Interstitial Lung Diseases
Unit, Hospital for Diseases of the Chest,
“Sotiria”, Medical School, National and
Kapodistrian University of Athens, Athens,
Greece
Corresponding author
Demosthenes Bouros
First Academic Department of Pneumonology, Hospital for Diseases of the Chest, “Sotiria”, Medical School, National and Kapodistrian University of Athens 152 Messogion Aven., Athens 11527, Greece
First Academic Department of Pneumonology, Hospital for Diseases of the Chest, “Sotiria”, Medical School, National and Kapodistrian University of Athens 152 Messogion Aven., Athens 11527, Greece
Pneumon 2018;31(4):203-204
REFERENCES (7)
1.
Jani AA, Uyeki TM. Chapter 46. Influenza. In: Emergency management of infectious diseases. 2nd ed. Chin RL, ed. Cambridge, UK: Cambridge University Press, 2018.
2.
Dimitroulis I, Katsaras M, Toumbis M. H1N1 infection and embolic events A multifaceted disease. Pneumon 2016; 29:230-35.
3.
Dimakakos E, Grapsa D, Vathiotis I, et al; H1N1-Induced Venous Thromboembolic Events? Results of a Single-Institution Case Series, Open Forum Infectious Diseases, Volume 3, Issue 4, 1 October 2016, ofw214, https://doi.org/10.1093/ofid/o....
4.
Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2017–18 influenza season. MMWR Recomm Rep 2017; 66:1-20.
5.
Uyeki T, Bernstein HH, Bradley SJ, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza (2018). Clinical Infectious Diseases 2018; pp. 1-47. DOI: 10.1093/cid/ciy866 [Epub ahead of print].
6.
Fiore EA, Fry A, Shay D, Gubareva L, Bresee SJ, Uyeki MT; Centers for Disease Control and Prevention (CDC). Recommendations and Reports “Antiviral agents for the treatment and chemoprophylaxis of influenza”. Influenza Division, National Center for Immunization and Respiratory Diseases 2011; 60:1-24.
7.
Hayden GF, Sugaya N, Hirotsu N, et al, for the Baloxavir Marboxil Investigators Group. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N Engl J Med 2018; 379:913-23. DOI: 10.1056/NEJMoa1716197.
| eISSN: | 1791-4914 |
| ISSN: | 1105-848X |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
